Compare AOUT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | STRO |
|---|---|---|
| Founded | 2020 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.7M | 85.0M |
| IPO Year | 2020 | N/A |
| Metric | AOUT | STRO |
|---|---|---|
| Price | $8.34 | $22.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 8 |
| Target Price | $12.50 | ★ $18.88 |
| AVG Volume (30 Days) | 36.3K | ★ 122.1K |
| Earning Date | 06-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $222,322,000.00 | N/A |
| Revenue This Year | N/A | $63.08 |
| Revenue Next Year | $8.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.55 | N/A |
| 52 Week Low | $6.26 | $0.52 |
| 52 Week High | $13.73 | $27.96 |
| Indicator | AOUT | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 62.18 |
| Support Level | $8.15 | $0.76 |
| Resistance Level | $8.91 | $27.96 |
| Average True Range (ATR) | 0.46 | 2.13 |
| MACD | -0.09 | -0.12 |
| Stochastic Oscillator | 39.01 | 49.29 |
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.